Enovis Co. (NYSE:ENOV – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued ratings on the stock in the last […]
Enovis (NYSE:ENOV – Free Report) had its price target boosted by Needham & Company LLC from $62.00 to $70.00 in a research note released on Friday, Marketbeat Ratings reports. Needham & Company LLC currently has a buy rating on the stock. Separately, Roth Mkm initiated coverage on Enovis in a research report on Friday, October […]
Enovis, an orthopedic-focused medical technology company, announces a leadership transition plan, including the appointment of two new executive officers and cu
By Colin Kellaher Enovis Corp.'s number-two executive plans to retire from the medical-technology company in early 2025. Enovis on Tuesday said Brady Shirley.
Enovis (NYSE:ENOV – Get Free Report) issued its earnings results on Tuesday. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.54 by $0.02, MarketWatch Earnings reports. The firm had revenue of $417.50 million during the quarter, compared to analysts’ expectations of $414.89 million. Enovis had a positive return on equity […]